Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 16 | 2022 | 3250 | 2.210 |
Why?
|
Electronic Health Records | 16 | 2025 | 4887 | 1.140 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2021 | 558 | 0.900 |
Why?
|
Nervous System Diseases | 3 | 2021 | 1662 | 0.650 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2017 | 10 | 0.600 |
Why?
|
Hypesthesia | 1 | 2017 | 106 | 0.560 |
Why?
|
Paralysis | 1 | 2017 | 250 | 0.520 |
Why?
|
Minocycline | 1 | 2017 | 170 | 0.520 |
Why?
|
Pandemics | 7 | 2022 | 8747 | 0.490 |
Why?
|
Receptor, Serotonin, 5-HT2A | 3 | 2004 | 64 | 0.480 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 320 | 0.460 |
Why?
|
Family Health | 1 | 2017 | 1255 | 0.390 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.370 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2744 | 0.360 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.350 |
Why?
|
Colitis, Ulcerative | 5 | 2013 | 1926 | 0.330 |
Why?
|
Lower Extremity | 1 | 2017 | 1217 | 0.330 |
Why?
|
Environment | 1 | 2015 | 1121 | 0.330 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2010 | 110 | 0.320 |
Why?
|
Meningitis | 1 | 2010 | 219 | 0.310 |
Why?
|
Immunologic Factors | 2 | 2017 | 1596 | 0.300 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15949 | 0.300 |
Why?
|
Phenotype | 6 | 2022 | 16726 | 0.300 |
Why?
|
Registries | 2 | 2021 | 8375 | 0.290 |
Why?
|
Comorbidity | 2 | 2020 | 10590 | 0.260 |
Why?
|
Algorithms | 8 | 2022 | 14164 | 0.260 |
Why?
|
Social Environment | 2 | 2020 | 1012 | 0.230 |
Why?
|
Pyramidal Cells | 2 | 2004 | 367 | 0.220 |
Why?
|
Alleles | 2 | 2012 | 6894 | 0.220 |
Why?
|
Data Collection | 2 | 2023 | 3326 | 0.220 |
Why?
|
Hospitalization | 9 | 2022 | 10840 | 0.210 |
Why?
|
Killer Cells, Natural | 1 | 2012 | 2211 | 0.200 |
Why?
|
Receptors, Serotonin | 1 | 2003 | 211 | 0.200 |
Why?
|
Natural Language Processing | 5 | 2025 | 1203 | 0.190 |
Why?
|
Myelitis, Transverse | 1 | 2021 | 40 | 0.190 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2021 | 68 | 0.180 |
Why?
|
Cell Polarity | 1 | 2004 | 639 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2892 | 0.180 |
Why?
|
Recurrence | 3 | 2021 | 8509 | 0.170 |
Why?
|
Crohn Disease | 4 | 2013 | 2295 | 0.170 |
Why?
|
British Columbia | 1 | 2020 | 240 | 0.170 |
Why?
|
Dendrites | 1 | 2003 | 472 | 0.170 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2021 | 75 | 0.170 |
Why?
|
Adult | 22 | 2025 | 223646 | 0.170 |
Why?
|
Disability Evaluation | 2 | 2017 | 1835 | 0.160 |
Why?
|
Optic Neuritis | 1 | 2021 | 175 | 0.160 |
Why?
|
Humans | 50 | 2025 | 768171 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 16044 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 18065 | 0.150 |
Why?
|
Female | 29 | 2025 | 397187 | 0.150 |
Why?
|
Male | 29 | 2025 | 364731 | 0.150 |
Why?
|
Cohort Studies | 9 | 2022 | 41753 | 0.150 |
Why?
|
Middle Aged | 18 | 2025 | 223487 | 0.150 |
Why?
|
Markov Chains | 2 | 2022 | 979 | 0.150 |
Why?
|
Models, Biological | 1 | 2013 | 9497 | 0.140 |
Why?
|
Cerebral Cortex | 2 | 2004 | 5812 | 0.140 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 271 | 0.140 |
Why?
|
Interferon-beta | 1 | 2018 | 349 | 0.130 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.130 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14783 | 0.120 |
Why?
|
Disease | 1 | 2020 | 675 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2020 | 937 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 942 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2003 | 4413 | 0.110 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 257 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2121 | 0.100 |
Why?
|
Guanine Nucleotides | 1 | 2012 | 55 | 0.100 |
Why?
|
Chemokine CCL4 | 1 | 2012 | 127 | 0.100 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2012 | 38 | 0.100 |
Why?
|
Disease Progression | 2 | 2021 | 13668 | 0.100 |
Why?
|
MELAS Syndrome | 1 | 2012 | 55 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2748 | 0.090 |
Why?
|
Lymphopoiesis | 1 | 2012 | 133 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2012 | 306 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3436 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2013 | 3721 | 0.090 |
Why?
|
Lymphocyte Count | 1 | 2012 | 794 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 26379 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 330 | 0.080 |
Why?
|
Self Report | 1 | 2021 | 3773 | 0.080 |
Why?
|
Brain | 3 | 2017 | 27362 | 0.080 |
Why?
|
Alzheimer Disease | 1 | 2010 | 8759 | 0.080 |
Why?
|
Young Adult | 3 | 2021 | 60066 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4206 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2004 | 3276 | 0.080 |
Why?
|
Retrospective Studies | 11 | 2025 | 81760 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1353 | 0.070 |
Why?
|
Intracranial Hypertension | 1 | 2010 | 191 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2021 | 26421 | 0.070 |
Why?
|
Peer Review, Research | 1 | 2021 | 344 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3252 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.070 |
Why?
|
Immunophenotyping | 1 | 2012 | 1864 | 0.070 |
Why?
|
Steroids | 1 | 2012 | 938 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11930 | 0.070 |
Why?
|
Adolescent | 5 | 2022 | 89169 | 0.070 |
Why?
|
Pemphigoid, Bullous | 1 | 2008 | 110 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.070 |
Why?
|
Prognosis | 4 | 2021 | 30009 | 0.070 |
Why?
|
Cell Separation | 1 | 2012 | 1728 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 743 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3772 | 0.060 |
Why?
|
Infant | 3 | 2021 | 36535 | 0.060 |
Why?
|
Atrophy | 1 | 2010 | 1646 | 0.060 |
Why?
|
Child, Preschool | 3 | 2021 | 42669 | 0.060 |
Why?
|
Transfection | 2 | 2003 | 5756 | 0.060 |
Why?
|
Family | 1 | 2015 | 3209 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9613 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15869 | 0.060 |
Why?
|
Receptor Aggregation | 1 | 2004 | 72 | 0.060 |
Why?
|
Cognition | 3 | 2022 | 7073 | 0.060 |
Why?
|
Singapore | 1 | 2025 | 300 | 0.060 |
Why?
|
Child | 5 | 2022 | 80917 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12795 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36741 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1388 | 0.050 |
Why?
|
Publishing | 1 | 2021 | 837 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4620 | 0.050 |
Why?
|
Exercise | 1 | 2020 | 5954 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4064 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6610 | 0.050 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2003 | 31 | 0.050 |
Why?
|
Italy | 1 | 2025 | 856 | 0.050 |
Why?
|
Models, Neurological | 1 | 2010 | 1776 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13013 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2003 | 816 | 0.050 |
Why?
|
Phosphatidylinositols | 1 | 2003 | 280 | 0.050 |
Why?
|
Risk Factors | 6 | 2015 | 74944 | 0.050 |
Why?
|
Serotonin Receptor Agonists | 1 | 2003 | 151 | 0.050 |
Why?
|
Dendritic Spines | 1 | 2004 | 244 | 0.050 |
Why?
|
Hydrolysis | 1 | 2003 | 646 | 0.050 |
Why?
|
Mutation | 3 | 2013 | 30237 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5902 | 0.050 |
Why?
|
Models, Genetic | 1 | 2010 | 3447 | 0.040 |
Why?
|
Protein Binding | 2 | 2003 | 9343 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2003 | 930 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
Genotype | 2 | 2013 | 13045 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40220 | 0.040 |
Why?
|
Malaria, Falciparum | 1 | 2008 | 1077 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10397 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2003 | 1989 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3311 | 0.040 |
Why?
|
Aged | 7 | 2025 | 171502 | 0.040 |
Why?
|
Cricetinae | 1 | 2003 | 2423 | 0.040 |
Why?
|
Serotonin | 1 | 2004 | 1043 | 0.040 |
Why?
|
Cell Line | 2 | 2003 | 15602 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 13053 | 0.040 |
Why?
|
Personality | 1 | 2022 | 559 | 0.040 |
Why?
|
Plasmodium falciparum | 1 | 2008 | 1741 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7609 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24318 | 0.040 |
Why?
|
Cause of Death | 1 | 2008 | 3721 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59626 | 0.040 |
Why?
|
Automation | 1 | 2020 | 589 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 21538 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1951 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 65379 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5891 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2634 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2732 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6568 | 0.030 |
Why?
|
Language | 1 | 2025 | 1557 | 0.030 |
Why?
|
Prospective Studies | 3 | 2021 | 54924 | 0.030 |
Why?
|
Research | 1 | 2023 | 1979 | 0.030 |
Why?
|
Binding Sites | 1 | 2003 | 6019 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 109 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3628 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20225 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 311 | 0.030 |
Why?
|
Compassionate Use Trials | 1 | 2012 | 50 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8142 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2430 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10763 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10632 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 772 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15833 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3081 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 932 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 2709 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10099 | 0.020 |
Why?
|
United States | 2 | 2015 | 73039 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 830 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3437 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 937 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3275 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3886 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13290 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12543 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2012 | 872 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1680 | 0.020 |
Why?
|
Rats | 1 | 2003 | 23782 | 0.020 |
Why?
|
Animals | 4 | 2013 | 169285 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3110 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14729 | 0.020 |
Why?
|
Signal Transduction | 2 | 2013 | 23648 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2448 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4280 | 0.010 |
Why?
|
Monocytes | 1 | 2013 | 2605 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2278 | 0.010 |
Why?
|
Uganda | 1 | 2008 | 1361 | 0.010 |
Why?
|
Microscopy | 1 | 2008 | 909 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2923 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2873 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4355 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8230 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2012 | 2725 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3782 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39354 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2420 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 2442 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3781 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18415 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4978 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6669 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12840 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22290 | 0.010 |
Why?
|